Antimicrobial therapy for otitis media with effusion ('secretory' otitis media)
- PMID: 1683673
Antimicrobial therapy for otitis media with effusion ('secretory' otitis media)
Abstract
Objective: To determine the effectiveness of antimicrobial treatment for otitis media with effusion ("secretory" otitis media) in children.
Data source: We report the reexamination of a previously published study by Mandel et al that evaluated the efficacy of a 2-week course of antimicrobials (amoxicillin trihydrate) with and without a 4-week course of an oral decongestant-antihistamine combination in a double-blind, placebo-controlled, randomized trial involving 518 infants and children with otitis media with effusion.
Data synthesis: At 4 weeks, amoxicillin efficacy as determined by a tympanometric criterion (P = .121) or by a measure of improvement in hearing (P = .311) was insignificant. Only by otoscopic judgment, which is shown to contain a systematic bias as used in this clinical trial, could an argument be made for a marginal efficacy of amoxicillin at the 4-week end point. Logistic regression analyses of the combined effects of treatment and prognostic factors showed no significant differences between placebo- and antibiotic-treated groups for unilateral effusions and for bilateral effusions. When subjects with unilateral and bilateral effusions were combined, the estimated efficacy of antibiotic treatment was 12.3% by otoscopy (P = .014) and 4.8% by tympanometry (P = .171). We also demonstrate the sensitivity of outcome to diagnostic measures used and provide statistical evidence questioning the validity of otoscopic observations in this study. Six weeks after the termination of amoxicillin therapy, the recurrence of effusion was two to six times higher in the amoxicillin-treated children than in those treated with placebo (P = .001), and resolution of effusion was not significantly different among antibiotic and placebo groups (13.6% and 11.3%, respectively; P = .477).
Conclusions: Amoxicillin with and without decongestant-antihistamine combination is not effective for the treatment of persistent asymptomatic middle-ear effusions in infants and children.
Comment in
-
Secretory otitis media: the Cantekin affair.JAMA. 1992 Jun 10;267(22):3029; author reply 3030-1. doi: 10.1001/jama.267.22.3029d. JAMA. 1992. PMID: 1588711 No abstract available.
-
Secretory otitis media: the Cantekin affair.JAMA. 1992 Jun 10;267(22):3029; author reply 3030-1. doi: 10.1001/jama.267.22.3029b. JAMA. 1992. PMID: 1588713 No abstract available.
-
The Cantekin affair.JAMA. 1991 Dec 18;266(23):3333-7. JAMA. 1991. PMID: 1960835 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
